vs

Side-by-side financial comparison of Hub Cyber Security Ltd. (HUBC) and Avidity Biosciences, Inc. (RNA). Click either name above to swap in a different company.

Hub Cyber Security Ltd. is the larger business by last-quarter revenue ($13.9M vs $12.5M, roughly 1.1× Avidity Biosciences, Inc.). Hub Cyber Security Ltd. runs the higher net margin — -91.4% vs -1398.3%, a 1306.9% gap on every dollar of revenue.

The Hub Power Company Limited, colloquially known as HUBCO, is a Pakistani power company based in Karachi, Sindh. It was the first independent power producer (IPP) established in Pakistan, and before the termination of its energy agreement in October 2024, it was the largest IPP in the country. HUBCO is listed on the Pakistan Stock Exchange.

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

HUBC vs RNA — Head-to-Head

Bigger by revenue
HUBC
HUBC
1.1× larger
HUBC
$13.9M
$12.5M
RNA
Higher net margin
HUBC
HUBC
1306.9% more per $
HUBC
-91.4%
-1398.3%
RNA

Income Statement — Q4 FY2024 vs Q3 FY2025

Metric
HUBC
HUBC
RNA
RNA
Revenue
$13.9M
$12.5M
Net Profit
$-12.7M
$-174.4M
Gross Margin
25.6%
Operating Margin
-80.8%
-1513.5%
Net Margin
-91.4%
-1398.3%
Revenue YoY
434.0%
Net Profit YoY
-117.0%
EPS (diluted)
$-1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HUBC
HUBC
RNA
RNA
Q3 25
$12.5M
Q2 25
$3.8M
Q1 25
$1.6M
Q4 24
$13.9M
$3.0M
Q3 24
$2.3M
Q2 24
$15.7M
$2.0M
Q1 24
$3.5M
Q4 23
$2.2M
Net Profit
HUBC
HUBC
RNA
RNA
Q3 25
$-174.4M
Q2 25
$-157.3M
Q1 25
$-115.8M
Q4 24
$-12.7M
$-102.3M
Q3 24
$-80.4M
Q2 24
$-26.4M
$-70.8M
Q1 24
$-68.9M
Q4 23
$-60.4M
Gross Margin
HUBC
HUBC
RNA
RNA
Q3 25
Q2 25
Q1 25
Q4 24
25.6%
Q3 24
Q2 24
9.5%
Q1 24
Q4 23
Operating Margin
HUBC
HUBC
RNA
RNA
Q3 25
-1513.5%
Q2 25
-4448.7%
Q1 25
-8360.9%
Q4 24
-80.8%
-4069.6%
Q3 24
-4200.9%
Q2 24
-95.7%
-4040.4%
Q1 24
-2178.6%
Q4 23
-3043.5%
Net Margin
HUBC
HUBC
RNA
RNA
Q3 25
-1398.3%
Q2 25
-4089.3%
Q1 25
-7360.0%
Q4 24
-91.4%
-3439.5%
Q3 24
-3441.7%
Q2 24
-167.8%
-3461.8%
Q1 24
-1943.4%
Q4 23
-2756.2%
EPS (diluted)
HUBC
HUBC
RNA
RNA
Q3 25
$-1.27
Q2 25
$-1.21
Q1 25
$-0.90
Q4 24
$-0.80
Q3 24
$-0.65
Q2 24
$-0.65
Q1 24
$-0.79
Q4 23
$-0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HUBC
HUBC
RNA
RNA
Cash + ST InvestmentsLiquidity on hand
$3.1M
$350.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-80.8M
$1.9B
Total Assets
$27.4M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HUBC
HUBC
RNA
RNA
Q3 25
$350.2M
Q2 25
$243.9M
Q1 25
$254.2M
Q4 24
$3.1M
$219.9M
Q3 24
$370.2M
Q2 24
$1.2M
$575.8M
Q1 24
$471.4M
Q4 23
$185.1M
Stockholders' Equity
HUBC
HUBC
RNA
RNA
Q3 25
$1.9B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$-80.8M
$1.4B
Q3 24
$1.5B
Q2 24
$-59.4M
$1.2B
Q1 24
$830.9M
Q4 23
$500.8M
Total Assets
HUBC
HUBC
RNA
RNA
Q3 25
$2.1B
Q2 25
$1.4B
Q1 25
$1.5B
Q4 24
$27.4M
$1.6B
Q3 24
$1.6B
Q2 24
$28.6M
$1.3B
Q1 24
$951.5M
Q4 23
$628.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HUBC
HUBC
RNA
RNA
Operating Cash FlowLast quarter
$-6.3M
$-156.2M
Free Cash FlowOCF − Capex
$-156.9M
FCF MarginFCF / Revenue
-1257.6%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-592.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HUBC
HUBC
RNA
RNA
Q3 25
$-156.2M
Q2 25
$-199.7M
Q1 25
$-124.8M
Q4 24
$-6.3M
$-99.9M
Q3 24
$-65.6M
Q2 24
$-10.8M
$-65.0M
Q1 24
$-70.4M
Q4 23
$16.5M
Free Cash Flow
HUBC
HUBC
RNA
RNA
Q3 25
$-156.9M
Q2 25
$-203.0M
Q1 25
$-128.6M
Q4 24
$-103.8M
Q3 24
$-67.3M
Q2 24
$-65.5M
Q1 24
$-71.3M
Q4 23
$15.6M
FCF Margin
HUBC
HUBC
RNA
RNA
Q3 25
-1257.6%
Q2 25
-5277.1%
Q1 25
-8174.3%
Q4 24
-3491.0%
Q3 24
-2881.8%
Q2 24
-3204.6%
Q1 24
-2012.3%
Q4 23
713.1%
Capex Intensity
HUBC
HUBC
RNA
RNA
Q3 25
5.7%
Q2 25
86.9%
Q1 25
238.6%
Q4 24
131.7%
Q3 24
72.9%
Q2 24
26.0%
Q1 24
25.8%
Q4 23
39.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons